BRIEF-Novo Nordisk Announces New Multi-Month Subscription Program For Wegovy For Eligible Self-Pay Patients

WW International, Inc. +2.91%
LifeMD, Inc. +3.81%
Hims & Hers Health +6.78%

WW International, Inc.

WW

10.98

+2.91%

LifeMD, Inc.

LFMD

4.09

+3.81%

Hims & Hers Health

HIMS

28.82

+6.78%

March 31 (Reuters) - Novo Nordisk A/S NOVOb.CO:

  • NOVO NORDISK: ANNOUNCED NEW MULTI-MONTH SUBSCRIPTION PROGRAM FOR WEGOVY FOR ELIGIBLE SELF-PAY PATIENTS

  • NOVO NORDISK: WEGOVY SUBSCRIPTION PROGRAM TO BE AVAILABLE FROM MAR 31 THROUGH RO, WEIGHTWATCHERS, LIFEMD

  • NOVO NORDISK: WEGOVY SUBSCRIPTION PROGRAM THROUGH HIMS & HERS, SESAME & OTHERS TO FOLLOW SOON

  • NOVO NORDISK: WEGOVY PEN ALL DOSES SUBSCRIPTION PLANS FOR 3-MONTHS AT $329/MONTH, 6-MONTHS AT $299/MONTH, 12-MONTHS AT $249/MONTH

  • NOVO NORDISK: WEGOVY PILL 9 MG, 25 MG DOSES SUBSCRIPTION PLANS FOR 3-MONTHS AT $289/MONTH, 6-MONTHS AT $269/MONTH, 12-MONTHS AT $249/MONTH

Further company coverage: [NOVOb.CO]


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.